Navigation Links
Investigational Study Evaluates the Effectiveness of Aripiprazole,in Adolescents With Schizophrenia

and periodic fasting blood glucose testing. Patients who develop symptoms of hyperglycemia should also undergo fasting blood glucose testing. There have been few reports of hyperglycemia with aripiprazole

Aripiprazole may be associated with orthostatic hypotension and should be used with caution in patients with known cardiovascular disease, cerebrovascular disease, or conditions which would predispose them to hypotension.

As with other antipsychotic drugs, aripiprazole should be used with caution in patients with a history of seizures or with conditions that lower the seizure threshold.

Like other antipsychotics, aripiprazole may have the potential to impair judgment, thinking, or motor skills. Patients should not drive or operate hazardous machinery until they are certain aripiprazole does not affect them adversely.

Disruption of the body's ability to reduce core body temperature has been attributed to antipsychotics. Appropriate care is advised for patients who may exercise strenuously, be exposed to extreme heat, receive concomitant medication with anticholinergic activity, or be subject to dehydration.

As antipsychotics have been associated with esophageal dysmotility and aspiration, aripiprazole should be used cautiously in patients at risk for aspiration pneumonia.

As the possibility of a suicide attempt is inherent in psychotic illness and bipolar disorder, close supervision of high-risk patients should accompany drug therapy. Prescriptions for aripiprazole should be written for the smallest quantity consistent with good patient management to reduce the risk of overdose.

Physicians should determine if a patient is pregnant or intends to become pregnant while taking aripiprazole. Patients should be advised not to breast- feed while taking aripiprazole.

Physicians should advise patients to avoid alcohol while taking aripiprazole.

Both CYP3A4 and CYP2D6 are responsible for arip
'"/>




Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
2. An Investigational Study Released at ADA Showed that Initial Combination Therapy with Januvia (sitagliptin) and Metformin Led to Improvement in Markers of Beta Cell Function in Patients with Type 2 Diabetes
3. Late Breaking Data Released at ADA Showed that the Investigational Use of Januvia and Metformin as Initial Combination Therapy Provided Significant Glucose Lowering Efficacy over 54 Weeks in Patients with Type 2 Diabetes
4. Investigational Study Demonstrated a Re-Establishment of Clinical Improvement with Orencia (Abatacept) in Children with Juvenile Idiopathic Arthritis upon Re-Introduction of Therapy
5. Mercks Investigational Migraine Treatment MK-0974 Significantly Improved Migraine Pain on Several Efficacy Measures in a Phase II Study
6. Data Demonstrated Metastatic Melanoma Response to Investigational Immunotherapy Ipilimumab
7. Investigational Drug Cediranib (AZD2171) Shows Promise in Patients With Recurrent Glioblastoma (GBM)
8. Additional New Data from Satraplatin SPARC Phase 3 Investigational Trial Presented at ASCO Annual Meeting
9. Additional New Data from Satraplatin SPARC Phase 3 Investigational Trial Presented at ASCO Annual Meeting
10. Investigational Cancer Drug Pertuzumab Shows Promising Results in Advanced Breast Cancer When Combined with Herceptin
11. Shire Announces Positive Results of Studies With Guanfacine Extended Release, An Investigational Nonstimulant Medication Filed for the Treatment of ADHD in Children and Adolescents
Post Your Comments:
(Date:8/27/2015)... 2015 Biosimilars are not generics and ... Food and Drug Administration (FDA) for recognizing that ... draft guidance issued today. The FDA,s draft guidance ... names, calling for biological products to bear a ... proposal reflects the agency,s thinking that "there is ...
(Date:8/27/2015)... India , August 27, 2015 According ... Product (Transfer, Hammock, Toilet, Seating, Universal, Standing, Bariatric ), Material (Nylon, ... - Forecast to 2020", published by MarketsandMarkets, the Medical Lifting Sling ... USD 411.5 Million in 2015, at a CAGR of 11.4 % ... 136 ma rket data T ables and ...
(Date:8/27/2015)... , Aug. 27, 2015  Now that Intuitive Surgical, ... Vinci S™ surgical robot, hospitals with robotic surgery programs ... also need to see where they stand with robotic ... right patients? Have they adopted best practices for safety? ... in the future? ECRI Institute, which has ...
Breaking Medicine Technology:Biologics Prescribers Collaborative (BPC) Statement on FDA Draft Guidance entitled "Nonproprietary Naming of Biological Products" 2Medical Lifting Sling Market Worth USD 706.0 Million by 2020 2Medical Lifting Sling Market Worth USD 706.0 Million by 2020 3Medical Lifting Sling Market Worth USD 706.0 Million by 2020 4ECRI Institute's New Robotic Surgery Service Helps Hospitals Brace for Change 2ECRI Institute's New Robotic Surgery Service Helps Hospitals Brace for Change 3
... Cannabis Science, Inc. (OTCBB: CBIS.OB), a pioneering US ... report an additional, apparently successful, self-medicated cannabis treatment for ... nature. One of the patient,s physicians said it was ... had ever seen, while another refused to continue tending ...
... 2012 Fleming Pharmaceuticals announced today that, effective December ... branded Ocean®, Nephrocaps®, Magonate® and ProBarimin QT® products to ... affiliate, Valeant Pharmaceuticals North America LLC, to act as ... Fleming also manufactures contract products for a broad ...
Cached Medicine Technology:Cannabis Science Reports Apparent Success for 3rd Self-Medicated Cancer Patient 2Cannabis Science Reports Apparent Success for 3rd Self-Medicated Cancer Patient 3
(Date:8/30/2015)... ... August 30, 2015 , ... Nutritional Products International ... the expansion of global cosmeceutical and skin care brands. Mr. Fernandez comes ... last 25 years working in operations, purchasing and management for some of the ...
(Date:8/29/2015)... ... August 30, 2015 , ... ... 2015 — 1:30 p.m. – 3:00 p.m. EDT, http://www.fdanews.com/electronicinformedconsent , The ... simple digital handwritten signature. , Clinical trial sites can now use ...
(Date:8/29/2015)... ... August 29, 2015 , ... Dr. Tim Novelli, DC., Founder and President ... to increase acceptance of the chiropractic field in the military. All too often VA ... Although Chiropractic was made available to the VA program over a decade ago, the ...
(Date:8/29/2015)... ... August 29, 2015 , ... Hamstring ... area with stretching, soft tissue manipulation. Platelet rich plasma injections also have ... research to improve treatment outcomes. This localized treatment seems to address the ...
(Date:8/28/2015)... Vegas, Nevada (PRWEB) , ... August 28, 2015 , ... ... announcing its decision to make the purchase of CPAP equipment more affordable by offering ... offer includes all types of CPAP products and orders of any size. My Cpap ...
Breaking Medicine News(10 mins):Health News:NPI Executive Vice President Leads Cosmeceutical Expansion 2Health News:FDAnews Announces — Electronic Informed Consent for Clinical Trials: Best Practices Webinar, Sept. 15, 2015 2Health News:FDAnews Announces — Electronic Informed Consent for Clinical Trials: Best Practices Webinar, Sept. 15, 2015 3Health News:FDAnews Announces — Electronic Informed Consent for Clinical Trials: Best Practices Webinar, Sept. 15, 2015 4Health News:The Patriot Project brings Chiropractic Care to the Armed Forces and their Families - Rapid Release Technology Joins the Effort to Recruit more Doctors to Pledge 2Health News:NEW APPROACH for Treatment of Recurrent Hamstring Strains and Hamstring Tendinosis is Available for the First Time in NYC 2Health News:NEW APPROACH for Treatment of Recurrent Hamstring Strains and Hamstring Tendinosis is Available for the First Time in NYC 3Health News:My Cpap Store Now Offering Delivery Special 0 Cost to You 2
... those who have been hospitalized, risk may double over 7 ... Certain depressed patients who suffer from heart disease have nearly ... with other depressed patients, researchers say. , The patients ... severe depression within a few weeks of being hospitalized for ...
... of Tropical Medicine (LSTM) and Liverpool Associates in Tropical ... UK,s Department for International Development (DFID) to set up ... The IHLC will act as a ,one-stop-shop, source ... developers of links and those wishing to strengthen existing ...
... complications seen with ,after-hours, procedures, study finds , MONDAY, ... slot to undergo an orthopedic procedure may lower your ... new study has found. , The study, published ... Bone and Joint Surgery , found little difference otherwise ...
... Regurin(R) XL (trospium chloride), a,once-daily, prolonged-release capsule to ... the UK. Regurin(R) XL provides rapid,significant and consistent improvements ... for central nervous system (CNS) side effects(2-7). , ... is a condition that results from,sudden, involuntary contraction of ...
... ... supplier of medical devices, today announced FDA clearance of new RT50 wireless stimulator modules ... stimulation (FES) motorized ergometer system. , ... Baltimore, MD(PRWEB) September 5, 2009 -- Restorative Therapies, Inc., a designer ...
... , , ... Cell Technologies, Inc., ("Stemedica"), a world leader in stem cell research ... breakthrough stem cell and related technology. The Jordanian Stem Cell ... the technology from Stemedica,s wholly-owned subsidiary, Stemedica International, S.A. The ...
Cached Medicine News:Health News:Severe, Lasting Depression Tied to Heart Patient Deaths 2Health News:Creation of international health links center 2Health News:Let Orthopedic Surgery Wait Until Morning When Possible 2Health News:REGURIN(R) XL (trospium chloride) Once Daily Tablets Now Available in the UK for the Treatment of Overactive Bladder 2Health News:REGURIN(R) XL (trospium chloride) Once Daily Tablets Now Available in the UK for the Treatment of Overactive Bladder 3Health News:REGURIN(R) XL (trospium chloride) Once Daily Tablets Now Available in the UK for the Treatment of Overactive Bladder 4Health News:REGURIN(R) XL (trospium chloride) Once Daily Tablets Now Available in the UK for the Treatment of Overactive Bladder 5Health News:Restorative Therapies, Inc., Receives FDA Clearance for RT300 Enhancements 2Health News:Restorative Therapies, Inc., Receives FDA Clearance for RT300 Enhancements 3Health News:The Jordanian Stem Cell Company Acquires Stem Cell Technology From Stemedica International S.A. 2Health News:The Jordanian Stem Cell Company Acquires Stem Cell Technology From Stemedica International S.A. 3
Colloidal Gold Conjugated, Rabbit anti-goat IgG (H&L) - 12 OD...
Colloidal Gold Conjugated, Protein A - 50 OD...
Colloidal Gold Conjugated, Protein G - 50 OD...
Polyester ribbon impregnated with conjugated Protein G - .25 OD per sq. cm....
Medicine Products: